Transition From Intraoperative Vancomycin‐Piperacillin Tazobactam to Vancomycin‐Cefepime Does Not Change Acute Kidney Injury or Renal Recovery Outcomes in Patients Undergoing Heart Transplantation

Documenti analoghi

• Implementation of a Protocol With a Shortened Vancomycin Prophylaxis Duration is Associated With Reduced Acute Kidney Injury in Lung Transplant Recipients: A Quasi‐Experimental Study
  di: Paige T. Stratton, et al.
  Pubblicazione: (2025)
• Colonization by Vancomycin‐Resistant Enterococci in Liver Transplantation: Risk Factors and Survival Impact
  di: Nathalia Neves Nunes, et al.
  Pubblicazione: (2025)
• Kidney Transplantation From Donors With Malignant Renal Masses: A Systematic Review
  di: Vincenzo Villani, et al.
  Pubblicazione: (2024)
• Association of Vancomycin Plus Piperacillin‐Tazobactam With Acute Kidney Injury: Differentiating Pseudo‐Injury From True Nephrotoxicity
  di: Congqin Chen, et al.
  Pubblicazione: (2025)
• Incidence and Risk Factors for Stroke After Combined Heart‐Kidney and Heart‐Liver Transplantation
  di: Armaan F. Akbar, et al.
  Pubblicazione: (2024)